Sebastian Gold
Mar 12, 2020

Biocon, Mylan win patent violation suit filed by Sanofi in US over insulin glargine device

Biopharmaceutical firm Biocon on March 11 said its partner Mylan has won a US court ruling that invalidated a Sanofi patent on an insulin glargine device.

https://www.moneycontrol.com/news/business/companies/biocon-mylan-win-patent-violation-suit-filed-by-sanofi-in-us-over-insulin-glargine-device-5023301.html